Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLA1 | P09884 | 2/20 | 0.35 |
| ▸ | DNTT | P04053 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29210938 | 0.94 | POLA1 (0.43) | POLA1DNTTPOLB | |
| SCHEMBL3431677 | 0.90 | — | — | |
| SCHEMBL15921915 | 0.82 | — | — | |
| SCHEMBL20994065 | 0.77 | — | — | |
| SCHEMBL2975191 | 0.75 | POLA1 (0.39) | POLA1DNTTPOLB | |
| SCHEMBL9423932 | 0.73 | POLA1 (0.30) | POLA1 | |
| SCHEMBL39811 | 0.73 | POLA1 (0.38) | POLA1DNTTPOLB | |
| SCHEMBL23853020 | 0.73 | — | — | |
| SCHEMBL6276544 | 0.69 | POLA1 (0.47) | POLA1DNTTPOLB | |
| SCHEMBL3650233 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117384013-A | Method for generating hydroxyl radical by utilizing Schiff base cerium complex | 上海致同建设工程科技有限公司 | 2024-01-12 | — | — | CN | disclosed |
| EP-2912016-A1 | NOVEL CATALYST COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2015-09-02 | — | — | EP | disclosed |
| WO-2014066602-A1 | NOVEL CATALYST COMPOSITIONS AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-05-01 | — | — | WO | disclosed |
| EP-2401074-A1 | ALKOXYLATION PROCESSES AND CATALYSTS THEREFOR | Dow Global Technologies LLC (US) | 2012-01-04 | — | — | EP | disclosed |
| US-20070134338-A1 | Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology | KANSAS UNIVERSITY OF, THE | 2007-06-14 | — | — | US | disclosed |
| WO-2006133354-A2 | METHODS FOR PRODUCING NANOPARTICULATE METAL COMPLEXES AND ALTERING NANOPARTICLE MORPHOLOGY | UNIVERSITY OF KANSAS (US) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070134338-A1 | Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology | NCSTN, NCLN, NCDN | POLA1 2289/4885DNTT 2052/4885POLB 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.